House Committee Investigates ESA Safety, Urges Amgen, J&J, To Stop Promotions.
NIH Director Calls For Lifting Federal Ban on Embryonic Stem Cell Research.
FDA Tightens Conflict of Interest Rules For Advisors.
Fox Chase Cancer Center Board Selects Michael Seiden of Dana-Farber/Harvard As New President.
ASCO Study Predicts Shortage of Oncologists.
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship - The Galleri MCD vote: What FDA asked its advisors to ignore
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish
